White Papers

Jul 13, 2016
Applied Clinical Trials
When a protocol calls for the collection of clinical outcome assessments, there are a number of factors which you must consider when it comes to deciding which method to implement in order to achieve the highest quality data outcomes. This eBook is designed to increase your knowledge about the range of eCOA modalities available in the market and aims to help you partner with your eCOA vendor to make well-informed choices regarding the best option for your unique study parameters.
Mar 18, 2016
Applied Clinical Trials
Many pharmaceutical, biotechnology and medical device companies have adopted globalization as a business model for their clinical trials. This model is especially pertinent within oncology with the number of competing trials consistently rising while patient access across North America and Western Europe has plateaued. While this geographic diversity of oncology trial sites has potential to open future markets, it also adds logistical hurdles ranging from import and export licenses to regulatory approval to variances in standard of care. This white paper explores several of the areas critical to the success of global oncology trials, including study planning, conducting feasibility and navigating regulatory submissions.
Mar 10, 2016
Applied Clinical Trials
Teaming up with Eli Lilly and DrugDev Advisory Board, eyeforpharma conducted a 'State of the Industry' survey to investigate how pharma is currently leveraging data and technology and how this will change over the next 2 years.
Mar 08, 2016
Applied Clinical Trials
Clinical trials using electronic Clinical Outcome Assessments (eCOA) benefit from compliance rates 300% higher than paper-based studies - but some sponsor shy away from eCOA adoption due to a misconception that paper diaries are cheaper. Read our eBook to understand the frequently neglected cost calculations proving that eCOA is the cost-effective and superior data collection solution for many clinical trials.
Jan 28, 2016
Applied Clinical Trials
The drug design process is a challenge in healthcare that calls for the better use of data at every turn. Download this article to uncover four ways pharmaceutical organizations and CROs can leverage patient-generated data from mobile health devices during the drug design process.
lorem ipsum